Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Hovnanian Alexander A.President |  HOVHOVNANIAN ENTERPRISES INCTax withholding | F | $81K 770 sh | Nov 4, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,252 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barker BrianDirector |  ACUACME UNITED CORPOption exercise | M | $109K 5,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Fenimore Christopher R.EVP Finance CFO |  REGNREGENERON PHARMACEUTICALS, INC.Gift | G | — 15 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $23K 208 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,036 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 14.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Tang MichaelSr VP, Secy & Chf Leg Ofc |  EMREMERSON ELECTRIC COTax withholding | F | $179K 1,073 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 19.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Oughtred SarahChief Financial Officer |  FIGSFIGS, Inc.Tax withholding | F | $468K 22.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Bernstein David CChief Accounting Officer |  ABNBAirbnb, Inc.Open-market sale · 10b5-1 plan | SELL | $294K 1,756 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Open-market sale · 10b5-1 plan | SELL | $50K 1,100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $87K 1,867 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $190K 4,000 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $98K 917 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $38K 1,025 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | van Houte HansChief Financial Officer |  NRIXNurix Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $24K 1,469 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Hasson Heather L.Director, Executive Chairman, 10% Owner | FIGSFIGS, Inc. Tax withholding | F | $642K 30.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Zuraitis MaritaDirector, President & CEO |  HMNHORACE MANN EDUCATORS CORP /DE/Open-market sale · 10b5-1 plan | SELL | $354K 7,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER |  MIRMMirum Pharmaceuticals, Inc.Option exercise · 10b5-1 plan | M | — 20.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Clark Joseph GatesSVP and Pres, Optimized LED |  PENGPenguin Solutions, Inc.Open-market sale · 10b5-1 plan | SELL | $70K 1,400 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Hall John TDirector, Chief Executive Officer | INTAIntapp, Inc. Open-market sale · 10b5-1 plan | SELL | $54K 1,200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Clark Joseph GatesSVP and Pres, Optimized LED | PENGPenguin Solutions, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 1,573 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Lewis Michelle ReneeChief Accounting Officer | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $159K 3,172 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $235K 5,080 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 10 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO |  VRSNVERISIGN INC/CAOpen-market sale · 10b5-1 plan | SELL | $12K 40 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 10 | Anderson RaymondDirector |  MNPRMonopar TherapeuticsOption exercise · 10b5-1 plan | M | $52K 1,740 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 10 | Epstein David RDirector |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $27K 370 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 10 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $147K 2,414 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 10 | Gordon William BDirector |  DUOLDuolingo, Inc.Open-market sale · 10b5-1 plan | SELL | $40K 300 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 10 | Anderson RaymondDirector | MNPRMonopar Therapeutics Open-market sale · 10b5-1 plan | SELL | $14K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 10 | Gordon William BDirector | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $40K 300 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 10 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | VRSNVERISIGN INC/CA Open-market sale · 10b5-1 plan | SELL | $37K 120 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 10 | Raabe Kyle AndrewPresident, Home Power Gen. |  GNRCGENERAC HOLDINGS INC.Open-market sale · 10b5-1 plan | SELL | $45K 212 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 10 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO | VRSNVERISIGN INC/CA Open-market sale · 10b5-1 plan | SELL | $37K 120 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 10 | Gordon William BDirector | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $40K 300 sh | Nov 4, 2026 traded Nov 2, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K